These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease. Esser N; Paquot N; Scheen AJ Expert Opin Investig Drugs; 2015 Mar; 24(3):283-307. PubMed ID: 25345753 [TBL] [Abstract][Full Text] [Related]
3. Inflammation and the etiology of type 2 diabetes. Sjöholm A; Nyström T Diabetes Metab Res Rev; 2006; 22(1):4-10. PubMed ID: 15991254 [TBL] [Abstract][Full Text] [Related]
4. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757 [TBL] [Abstract][Full Text] [Related]
7. Inflammation, cytokines and insulin resistance: a clinical perspective. Wieser V; Moschen AR; Tilg H Arch Immunol Ther Exp (Warsz); 2013 Apr; 61(2):119-25. PubMed ID: 23307037 [TBL] [Abstract][Full Text] [Related]
8. [Dyslipoproteinemia and metabolic syndrome. Effects of insulin resistance and hyperinsulinemia on lipid metabolism]. Krone W; Müller-Wieland D; Wirth H Fortschr Med; 1992 Dec; 110(34):645-8. PubMed ID: 1483617 [TBL] [Abstract][Full Text] [Related]
9. The endothelium and vascular inflammation in diabetes. Hartge MM; Unger T; Kintscher U Diab Vasc Dis Res; 2007 Jun; 4(2):84-8. PubMed ID: 17654441 [TBL] [Abstract][Full Text] [Related]
10. [Disorders of lipid metabolism in insulin resistance]. Müller-Wieland D; Krone W Herz; 1995 Feb; 20(1):33-46. PubMed ID: 7713475 [TBL] [Abstract][Full Text] [Related]
11. [Hyperinsulinemia--the common denominator in type II diabetes mellitus,obesity, hypertension, hypertriglyceridemia and atherosclerosis]. Málková J; Andĕl M; Stolba P; Kimlová I Cas Lek Cesk; 1994 Jan; 133(2):41-5. PubMed ID: 8131178 [TBL] [Abstract][Full Text] [Related]
12. [Insulin resistance and arterial hypertension]. Weidmann P; Müller-Wieland D; de Courten M; Krone W Herz; 1995 Feb; 20(1):16-32. PubMed ID: 7713473 [TBL] [Abstract][Full Text] [Related]
13. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II. Black PH Med Hypotheses; 2006; 67(4):879-91. PubMed ID: 16781084 [TBL] [Abstract][Full Text] [Related]
14. Insulin resistance and hypertension. Patients in double jeopardy for cardiovascular disease. McLaughlin T; Reaven G Geriatrics; 2000 Jun; 55(6):28-32, 35. PubMed ID: 10872343 [TBL] [Abstract][Full Text] [Related]
15. Role of insulin resistance in human disease (syndrome X): an expanded definition. Reaven GM Annu Rev Med; 1993; 44():121-31. PubMed ID: 8476236 [TBL] [Abstract][Full Text] [Related]
17. Type II diabetes and syndrome X. Pathogenesis and glycemic management. Karam JH Endocrinol Metab Clin North Am; 1992 Jun; 21(2):329-50. PubMed ID: 1612069 [TBL] [Abstract][Full Text] [Related]
19. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk. Chan JC; Tong PC; Critchley JA Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595 [TBL] [Abstract][Full Text] [Related]
20. The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control. Pedersen BK Essays Biochem; 2006; 42():105-17. PubMed ID: 17144883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]